Nov 20, 2012

Tropicamide now requires name-specific and quantitative accounting

Drugs marketed under international unpatented name Tropicamide are now listed as medications requiring name-specific and quantitative accounting at healthcare institutions.

The new regulation was issued per Directive of the Ministry of Healthcare of Ukraine No 845 of 29.10.2012 on the amendment of the Rules of Issuing Prescriptions and Orders for Medicinal Products and Medical Devices and of the Procedure of Selling Medicinal Products and Medical Devices at Drugstores and their Subdivisions approved by Directive of the Ministry of Healthcare of Ukraine No 360 of 19.07.2005, the press service of Apteka weekly reports.

Just as a reminder, the above document will come into force as of the official publication date. It is expected to be published in The Official Journal of Ukraine, issue No 87 dated 23.11.2012.

Back to the News

Previous Next

More news

Farmak Recognized as One of Best Employers in the Forbe...

Farmak, a leader in the Ukrainian market of medicines*, was included in TOP 50 of Best Employers of Ukraine, which was composed by Forbes jointly with recruitment website Robota.ua. While making the rating, Forbes and Robota.ua considered company employees’ questionnaires, opinions of recruiting experts, industry-specific editors of the outlet, and informati...

May 01, 2024

Farmak Took Part in the First Meeting of the EU Critica...

Farmak, a leader of the medicinal market in Ukraine, took part in the first meeting of the Critical Medicines Alliance Forum. The Alliance was launched by the European Commission in response to the Covid-19 Coronavirus pandemic. Its core task is to reduce the risk of deficit of essential medicines in the EU during the next […]

May 01, 2024

Farmak’s International Office acquires Polish Symphar

As of 27 March 2024, Farmak’s International Office has successfully finalized its acquisition of Symphar, becoming the sole owner of the Polish pharmaceutical company. The acquisition represents a part of Farmak’s international expansion strategy “Farmak 2.0: From local to global success”. This M&A is an important next step after last year’s ...

Mar 28, 2024